Search by Drug Name or NDC

    NDC 68382-0257-01 oxybutynin 15 mg/1 Details

    oxybutynin 15 mg/1

    oxybutynin is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is OXYBUTYNIN CHLORIDE.

    Product Information

    NDC 68382-0257
    Product ID 68382-257_f54e4d4e-91be-4e10-a446-57ed5e1843a1
    Associated GPIs 54100045207540
    GCN Sequence Number 042606
    GCN Sequence Number Description oxybutynin chloride TAB ER 24 15 MG ORAL
    HIC3 R1A
    HIC3 Description URINARY TRACT ANTISPASMODIC/ANTIINCONTINENCE AGENT
    GCN 93557
    HICL Sequence Number 002048
    HICL Sequence Number Description OXYBUTYNIN CHLORIDE
    Brand/Generic Generic
    Proprietary Name oxybutynin
    Proprietary Name Suffix n/a
    Non-Proprietary Name oxybutynin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 15
    Active Ingredient Units mg/1
    Substance Name OXYBUTYNIN CHLORIDE
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202332
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0257-01 (68382025701)

    NDC Package Code 68382-257-01
    Billing NDC 68382025701
    Package 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68382-257-01)
    Marketing Start Date 2017-08-10
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.15897
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description OXYBUTYNIN CL ER 15 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis